New tool for cutting DNA: Promising prospects for biotechnology

(Press-News.org) New tool for cutting DNA: promising prospects for biotechnology 

An INRS team discovers a new family of enzymes capable of inducing targeted cuts in single-stranded DNA  

A few years ago, the advent of technology known as CRISPR was a major breakthrough in the scientific world. Developed from a derivative of the immune system of bacteria, CRISPR enables double strands of nucleotides in deoxyribonucleic acid (DNA) to be cut.  This makes it possible to specifically modify a targeted gene in plant, animal and human cells. Ultimately, CRISPR became a preferred method in the search for treatments for acquired or hereditary diseases.  

Recently, Professor Frédéric Veyrier at the Institut national de la recherche scientifique (INRS) and his team developed a new genetic tool based on a family of specific enzymes called Ssn that allows targeted cuts to be induced exclusively in single-stranded DNA. 

The results of their work were recently published in the journal Nature Communications. This major breakthrough sheds light on a crucial genetic mechanism that could revolutionize a multitude of biotechnology applications. 

A form of DNA with a key role 

Single-stranded DNA is less common than double-stranded DNA. It is often found in some viruses and plays a key role in certain biological processes, such as cell replication or repair. Single-stranded DNA is also used in many technologies (sequencing, gene editing, molecular diagnostics, nanotechnology). 

To date, no endonuclease – enzyme that cuts DNA – has been described as exclusively targeting a single-stranded DNA sequence, which has constituted a barrier to the development of technologies based on this type of DNA. 

Now, for the first time in a laboratory, Professor Veyrier’s team has identified a family of enzymes capable of cutting a specific sequence in single-stranded DNA: the family of Ssn endonucleases.  

To achieve this, the research team at INRS’s Armand-Frappier Santé Biotechnologie Research Centre first characterized a new family of endonucleases part of the GIY-YIG superfamily called Ssn. More specifically, researchers focused on one of these enzymes in the bacterium Neisseria meningitidis, also known as the meningococcus. The enzyme targeted in the study is crucial to the exchange and alteration of genetic material, which influences evolution. 

“In studying it, we found that it recognizes a specific sequence that is found in many instances in its genome and plays a key role in the natural transformation of the bacterium. This interaction directly influences the dynamics of the bacterial genome,” explains Professor Veyrier, a specialist in genomic bacteriology and evolution. 

In addition to this fundamental discovery, INRS’s research scientists identified thousands of other similar enzymes. “We demonstrated that they are able to recognize and specifically cut their own single-stranded DNA sequence. Thousands of enzymes therefore have this property with their own specificity,” adds Alex Rivera-Millot, a postdoctoral fellow on Professor Veyrier’s team and co-first author of the study. 

Artwork depicting various sequences of single-stranded DNA being cleaved by distinct bacterial homologs of the novel Ssn enzyme family.  

Credit: Ella Maru Studio 

An undeniable asset for health research 

These results, which represent a new tool for DNA recognition and exchange, are significant. They pave the way to many novel applications in biology and medicine. On the one hand, understanding this mechanism could help better control the bacteria in question and the associated infections.  

On the other, the discovery of enzymes specific to single-stranded DNA makes it possible to develop more precise and efficient genetic manipulation tools. This could namely improve methods of gene editing, DNA detection and molecular diagnosis. These enzymes could also be used to detect and manipulate DNA in various medical and industrial applications, such as pathogen detection or genetic manipulation for medical and therapeutic purposes.  

All of these avenues hold significant promise for addressing many health issues. Currently, there is a patent pending for the results of this work.  

About the study  

Chenal, M.*, Rivera-Millot, A.*, Harrison, L.B. et al. Discovery of the widespread site-specific single-stranded nuclease family Ssn. Nat Commun 16, 2388 (2025). https://doi.org/10.1038/s41467-025-57514-1. 

This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canadian Institutes of Health Research (CIHR) and the Fonds de recherche du Québec – Santé (FRQS).

 

 

 

END